AI-POD Clinical Validation Study for Obese Patients
The AI-POD Clinical Validation Study targets patients with severe obesity undergoing a computerised tomography (CT) scan of the heart. It is a multi‑centre, controlled, open, randomised study involving 1,200 participants across Europe. Randomly selected participants will install a citizen app on their smartphone and receive a fitness tracker to record heart rate and daily steps.
The AI-POD Clinical Validation Study targets patients with severe obesity undergoing a computerised tomography (CT) scan of the heart. It is a multi‑centre, controlled, open, randomised study involving 1,200 participants across Europe. Randomly selected participants will install a citizen app on their smartphone and receive a fitness tracker to record heart rate and daily steps.
The study’s integration of AI‑driven data collection and analysis is relevant to Swiss AI research in medical imaging and wearable health analytics.
Original source record. Open the original record to verify the underlying announcement.